CHICAGO, July 9, 2015 (GLOBE NEWSWIRE) -- Merge Healthcare Incorporated (NASDAQ:MRGE), a leading provider of innovative enterprise imaging, interoperability, and clinical systems that seek to advance healthcare, today announced Summa Health, one of the largest integrated healthcare delivery systems in Ohio, will integrate Merge's cardiology solutions to support population health initiatives. The solutions will support Summa's overarching coordinated care goals, as well as provide better access to images and data to enhance workflows and reporting.
"By partnering with Merge, we are replacing disparate standalone cardiology applications and improving our ability to analyze data to drive process improvement," said Kellie Nace, system director for clinical imaging and document archive solutions. "Our goal is to have an all-in-one patient view, consolidate workflow for our clinicians, and enable an efficient structured reporting environment for all of our cardiology modalities."
Summa will leverage Merge cardiology and hemodynamic solutions, including:
- Merge Hemo™, Merge's real-time documentation tool for the cardiac cath lab, which easily automates cath lab documentation into the patient's electronic health record for efficient workflow.
- Merge Cardio™, a web-enabled enterprise-level image and information system that provides a single point of entry to the patient's complete cardio record spanning all cardiac modalities.
"We're excited to support Summa in their population health and wellness initiatives. With the trend toward value-based reimbursement, we know organizations are striving to provide better access to healthcare," said Justin Dearborn, chief executive officer at Merge Healthcare. "Through solutions that provide enterprise support, Summa's physicians will have a consolidated view of their patient's information, enabling quicker and more efficient patient care. Population health organizations, like Summa, are leading the charge in this arena to embrace greater collaboration, reduced costs and better patient outcomes."
To learn more about Merge's full suite of solutions, visit http://www.merge.com/Solutions.aspx.
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge's enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us @MergeHealthcare.
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words "will," "believes," "intends," "anticipates," "expects" and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.
CONTACT: Media Contact: Michael R. Klozotsky Vice President, Corporate Marketing 312.946.2535 Michael.Klozotsky@merge.com